A patent term extension (PTE) of up to five (5) years beyond the 20-year term is available for new pharmaceuticals under s70 of the Patents Act 1990. This benefit is to account for the lengthy regulatory approval process for medicinal products to come to market. The decision in Pharma Mar S.A. [2020] APO 8 relates … Continue reading Patent Term Extension: Two Part Mixture Deemed Ineligible in Australia